ACADIA Pharmaceuticals Inc.ACADNASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank36
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Percentile
P36
Within normal range
vs 5Y Ago
-5.9x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-33.11%
2024773.27%
202379.53%
202210.05%
202111.81%
20205.59%
201910.23%
201822.43%
20170.57%
2016-77.44%